Basic fibroblast growth factor (bFGF) is an established growth factor
for melanocytes and a potent angiogenic factor. The expression of bFGF
was investigated in 23 desmoplastic melanomas. (DM) (12 males, median
age 64 years, and 11 females, median age 54 years) by immunostaining
of formalin-fixed, paraffin-embedded sections with high-affinity purif
ied antibody raised against recombinant human bFGF (Scios Nova, Inc.).
The tumors were characterized by level II invasion in 1 case (5%), le
vel IV invasion in 11 cases (48%), level V invasion in 8 cases (35%),
and indeterminate in 3 cases. bFGF expression was observed in 22 of 23
tumors (95%), either immune localized to tumor cell nuclei in 17 of 2
2 tumors (77%), or to the cytoplasm of tumor cells in 5 of 22 tumors (
23%). Also in these cases, bFGF tvas strongly expressed in the nuclei
of vascular endothelial cells. Maximal expression was noted in the per
ipheral blood vessels of 20 tumors (91%) versus intratumoral vessels o
f 13 DM (59%). In conclusion, the expression of predominantly nuclear
bFGF by tumor cells in DM suggests a role in mediating the desmoplasti
c phenotype. In addition, the localization of bFGF to vascular endothe
lium, particularly at the periphery of the tumor, may be relevant to t
umor angiogenesis.